June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
PPARγ Regulates Meibocyte Differentiation and Lipid Synthesis of Cultured Human Meibomian Gland Epithelial (hMGE) Cells.
Author Affiliations & Notes
  • James Jester
    Gavin Herbert Eye Institute, UC Irvine, Irvine, California, United States
  • Yilu Xie
    Gavin Herbert Eye Institute, UC Irvine, Irvine, California, United States
  • Jonathan Sanghoon Kang
    Gavin Herbert Eye Institute, UC Irvine, Irvine, California, United States
  • Paul Quoc Hung Nguyen
    Gavin Herbert Eye Institute, UC Irvine, Irvine, California, United States
  • Vickie Thi Bui
    Gavin Herbert Eye Institute, UC Irvine, Irvine, California, United States
  • Kelly Huynh
    Gavin Herbert Eye Institute, UC Irvine, Irvine, California, United States
  • Donald J. Brown
    Gavin Herbert Eye Institute, UC Irvine, Irvine, California, United States
  • Footnotes
    Commercial Relationships   James Jester, None; Yilu Xie, None; Jonathan Kang, None; Paul Nguyen, None; Vickie Bui, None; Kelly Huynh, None; Donald Brown, None
  • Footnotes
    Support  Supported in part by NIH Grant EY021510, the Skirball Program in Molecular Ophthalmology, and Research to Prevent Blindness, Inc. Unrestricted Grant.
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4393. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      James Jester, Yilu Xie, Jonathan Sanghoon Kang, Paul Quoc Hung Nguyen, Vickie Thi Bui, Kelly Huynh, Donald J. Brown; PPARγ Regulates Meibocyte Differentiation and Lipid Synthesis of Cultured Human Meibomian Gland Epithelial (hMGE) Cells.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4393.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : PPARγ is a lipid sensitive nuclear receptor that regulates expression of genes involved in lipogenesis. In recent studies we have shown that PPARγ signaling is down regulated in aging human and mouse meibomian glands and up-regulates lipogenesis of mouse meibocytes in culture. The purpose of this study was to evaluate the role of PPARγ in regulating meibocyte differentiation and lipid synthesis in cultured hMGE cells.

Methods : Telomerized hMGE cells were cultured in DMEM/F12 supplemented with 10ng/ml EGF and exposed to the PPARγ agonist, Rosiglitazone (Rosi), at 10-50 μM. Cultures were also exposed to PPARγ antagonist, GW9662, to block Rosi effects. Cells were then fixed for staining with LipidTox to measure lipid synthesis, Ki67 to measure cell cycling, and antibodies to meibocyte differentiation proteins, PPARγ, ADFP, caspase 9, caspase 14 and ULK1 s556. Proteins were also collected for western blotting. All experiments were run in triplicate.

Results : Rosi induced a significant (P<.001) dose and time dependent increase in neutral lipid synthesis from 20-50 μM that peaked with 30 μM at day 6 after treatment (P<.001), increasing over 80 fold. Treating cells with the inhibitor, GW9662, at 20 μM and 50μM significantly blocked lipid synthesis induced by the concomitant treatment of 20 μM Rosi for 5 days by 64% (P<.001) and 89% (P<.001) respectively. Treatment with Rosi also induced significant (P<.001) loss of Ki67 labeling, which was reduced by 77%, 86% and 96% following 2 days of treatment with 10 μM, 30 μM and 50 μM respectively. Expression of PPARγ was also significantly increased ~4 fold following treatment with 30 μM and 50 μM Rosi (P<.025) as well as other differentiation markers including caspase 9, caspase 14, ADFP and ULK1 s556 identified by western blotting.

Conclusions : These results indicate that PPARγ receptor signaling specifically induces cell cycle exit of hMGE cells and meibocyte differentiation involving expression of meibocyte specific proteins and lipid synthesis. Overall, these findings support the hypothesis that PPARγ is a master regulator of meibocyte differentiation.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×